Discontinued Operations (Tables)

3 Months Ended

Mar. 31, 2021

Discontinued Operations and Disposal Groups [Abstract]

Summary of Discontinued Operations and Disposal Groups

The following table presents the operating results of the discontinued operations.

	Three Months Ended March 31, 2020
Net sales	$	83,532
Cost of sales (exclusive of depreciation and amortization shown separately below)	57,763
Selling, general, and administrative expense	8,405
Depreciation and amortization	11,827
Goodwill impairment	146,757
Other operating expense, net	3
Loss from operations	(141,223)
Interest expense	13,270
Other income, net	(424)
Loss from discontinued operations before costs of disposal and benefit for income taxes	(154,069)
Benefit for income taxes	14,187
Loss from discontinued operations before costs of disposal	(139,882)
Costs of disposal of discontinued operations (1)	(259)
Benefit for income taxes on costs of disposal	27
Loss from discontinued operations, net of tax	$	(140,114)

_______________________________

(1)Represents incremental direct costs related to the sale of the Life Sciences business that were incurred prior to the closing of the sale.

The following table summarizes the amount of interest expense related to the previous credit facility that has been reclassified to discontinued operations.

	Three Months Ended March 31, 2020
Interest on debt	$	12,136
Amortization of debt issuance costs	1,226
Capitalized interest and other	(223)
Other	131
Total interest expense of discontinued operations	$	13,270

The following table presents the significant noncash items and cash paid for capital expenditures of discontinued operations for each historical period presented.

	Three Months Ended March 31, 2020
Depreciation and amortization	$	11,827
Goodwill impairment	146,757
Amortization of debt issuance costs	1,226
Acquisition of property, plant and equipment	4,084
Right-of-use assets obtained in exchange for new finance lease liabilities	694